Clinical Trials Browser

Phase 2 × Not yet recruiting × apalutamide × Clear all

NCT05778097 2023-03-21

ARES

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT05717582 2023-02-08

CHAMPION

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Phase 2 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms